Cytotoxicity and aerodynamical testing of spray dried meloxicam forms for inhalation

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-C-009-Monday
• By: CHVATAL, Anita (University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, Szgede, Hungary)
• Co-author(s): Anita Chvatal: Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, Szeged, Hungary
  Rami Alzhrani: College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, United States
  Rita Ambrus: Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, Szeged, Hungary
  Piroska Szabóné-Révész: Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, Szeged, Hungary
  Amit Tiwari: College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, United States
  Sai H. S. Boddu: College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, United States
  
• Abstract:

  Backgrounds

  Meloxicam is a poorly water-soluble COX-2 enzyme inhibitor used in the treatment of rheumatoid arthritis following oral administration. The selective COX-2 enzyme inhibition of meloxicam makes it useful in the local treatment of cystic fibrosis and other lung inflammations via inhalation. For pulmonary drug delivery one of the most

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login